Third Circuit Vacates Trademark Infringement Award, Clarifying Standards to be Applied by Trial Courts – JD Supra
Third Circuit Vacates Trademark Infringement Award, Clarifying Standards to be Applied by Trial Courts JD Supra
Archive for December, 2021
-
In: TRADEMARK NEWS
-
In: PATENT NEWS
In-car biometrics recognize drivers, monitor vitals, detect left-behind children
The patent for the multi-camera biometric authentication method was … Subaru violated state biometric privacy data law with its DriverFocus …
-
In: PATENT NEWS
IP advisor – IamExpat
Extensive experience with intellectual property law and procedures, preferably as a patent attorney (or in training). Familiar with the world of …
-
In: PATENT NEWS
China Revokes Patent Licenses for Irregular Patent Applications – The National Law Review
China Revokes Patent Licenses for Irregular Patent Applications The National Law Review
-
In: PATENT NEWS
Patent war break: Daimler acquires 4G license from the Avanci patent pool – Market Research Telecast
Patent war break: Daimler acquires 4G license from the Avanci patent pool Market Research Telecast
-
In: PATENT NEWS
Top Section 101 Patent Eligibility Stories of 2021 | Holland & Knight LLP – JDSupra – JD Supra
Top Section 101 Patent Eligibility Stories of 2021 | Holland & Knight LLP – JDSupra JD Supra
-
In: PATENT NEWS
Prime Medical Loses Eligibility Challenge to Surgical Kit Patents – Bloomberg Law
Prime Medical Loses Eligibility Challenge to Surgical Kit Patents Bloomberg Law
-
In: PATENT NEWS
Look Back To Move Forward: Capturing IP Within The One-Year Grace Period – Intellectual Property – United States – Mondaq News Alerts
Look Back To Move Forward: Capturing IP Within The One-Year Grace Period – Intellectual Property – United States Mondaq News Alerts
-
In: PATENT NEWS
Forward Pharma granted Australian patent linked to multiple sclerosis therapy – Seeking Alpha
Forward Pharma granted Australian patent linked to multiple sclerosis therapy Seeking Alpha
-
In: COPYRIGHT NEWS
The FDA has authorized Merck’s COVID pill for home use — the 2nd in 2 days – WFAE
The FDA has authorized Merck’s COVID pill for home use — the 2nd in 2 days WFAE